ZYNERBA PHARMACEUTICALS, INC. Proceeds from Stock Options Exercised
ZYNERBA PHARMACEUTICALS, INC. reported Proceeds from Stock Options Exercised of $47.91 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-28
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2021-12-31 was $0.00.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2021-06-30 was $0.00.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2021-03-31 was $47.91K.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2021 was $47.91K.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2019 was $189.70K.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2017 was $434.69K.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from stock options exercised for fiscal 2015 was $63.51K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $47.91K 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $47.91K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $47.91K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $47.91K 10-Q · filed 2022-05-16 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $189.70K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $189.70K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $189.70K 10-Q · filed 2020-08-10 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $434.69K 10-K · filed 2020-03-10 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $434.69K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $434.69K 10-Q · filed 2018-08-02 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $63.51K 10-K · filed 2018-03-12 | ||
| 2015-09-30 | $63.51K 10-Q · filed 2016-11-14 |